anybody else thinking this news leaked late last week…
- Forums
- ASX - By Stock
- PAR
- Ann: Paradigm Secures Ethics Approval for Phase 3 Trial
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
3.23%
!
30.0¢

Ann: Paradigm Secures Ethics Approval for Phase 3 Trial, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
-0.010(3.23%) |
Mkt cap ! $116.8M |
Open | High | Low | Value | Volume |
31.0¢ | 31.0¢ | 30.0¢ | $62.67K | 203.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3389 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 18682 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 42746 | 0.290 |
7 | 98434 | 0.285 |
20 | 266210 | 0.280 |
5 | 61517 | 0.275 |
7 | 115424 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 42671 | 4 |
0.305 | 1 | 1 |
0.310 | 60251 | 4 |
0.315 | 61979 | 4 |
0.320 | 108906 | 8 |
Last trade - 12.10pm 18/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online